Figure 4.
Ketamine and UCMS interact to change mRNA levels of genes involved in glutamatergic and GABAergic transmission in the PFC. Top row (blue; A–C): in males, mRNA levels of NR1 and NR2A are significantly reduced by UCMS. NR2A mRNA levels are also reduced by ketamine, mostly in the control group. PV mRNA levels are significantly lower in the PFC of mice exposed to UCMS and ketamine. Bottom row (pink; D–F): in females, only PV mRNA levels were reduced by ketamine. N = 4–6 mice/group/sex. Data analyzed by two-way ANOVA. **p ≤ 0.01, ***p ≤ 0.001, $main ketamine effect for p ≤ 0.05, λdifferent than all other groups for p ≤ 0.03.